MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Quantifying postural stability differences in people with Parkinson’s disease with and without freezing of gait, using body-worn sensors

    P. Carlson-Kuhta, M. El-Gohary, M. Mancini, F. Horak, J. Huisinga (Portland, OR, USA)

    Objective: To quantify differences in postural responses to perturbations in people with Parkinson disease (PD) with and without freezing of gait (FOG+, FOG-, resp.), using…
  • 2017 International Congress

    Effects of different intensity exercises on motor function of PD rats as well as the regulation of DA

    x. Liu, p. Chen, d. Qiao, m. wang (Beijing, China)

    Objective: This paper research the intervention effect of the different intensity treadmill exercise on motor function of Parkinson 's diseases (PD) model rats,and explore the…
  • 2017 International Congress

    Cerebrotendinous xanthomatosis without tendon xanthoma: a diagnostic challenge.

    S. Souki, L. Vasconcellos, M. Spitz, J. Pereira, V. Marussi, A. Carrié, P. Couvert (Rio de Janeiro, Brazil)

    Objective: To describe the case of Cerebrotendinous xanthomatosis (CTX) without tendon xanthoma, highlighting the diagnostic challenge due to its rarity, as well as the importance…
  • 2017 International Congress

    Restless Legs Syndrome in hemodialyzed patients: a case-control study.

    I. Estrada-Bellmann, S. Castillo-Torres, C. Cerda-Contreras, J. Peña-Avendaño, D. Ortiz-Zacarías (Monterrey, Mexico)

    Objective: To determine the association between the clinical and paraclinical variables and the restless legs syndrome. Background: The restless legs syndrome (RLS) is a common…
  • 2017 International Congress

    Assessment of graphomotor impairment in patients with Spinocerebellar ataxia and Parkinson’s disease

    M. Thomas, A. Stezin, A. Lenka, N. Thota, P. Pal, R. Yadav (Bengaluru, India)

    Objective: The study aimed to assess the kinematic characteristics of handwriting in patients with Spinocerebellar ataxia (SCA) and to compare it with patients with Parkinson's disease…
  • 2017 International Congress

    Improved Detection of Gait Abnormalities in Parkinson’s disease using an IMU Sensor-based System

    B. Shiwani, S. Roy, J. Kline, M. Saint-Hilaire, C. Thomas, M. Gennert, G. De Luca (Natick, MA, USA)

    Objective: To develop an automated system that uses a limited set of IMU sensors to improve the detection of gait abnormalities in Parkinson’s disease during…
  • 2017 International Congress

    Alternative Apomorphine Challenge Test

    J.C. Martinez Castrillo, A. Alonso Canovas, C. Estevez Fraga, G. Sanchez Diez, I. Avilés Olmos, J. Lopez Sendon, P. Garcia Ruiz, L. Vela Desojo (Madrid, Spain)

    Objective: To propose a new apomorphine challenge test Background: In the standard apomorphine challenge test, the appropriate dose of apomorphine is established by incremental dosing…
  • 2017 International Congress

    Protocol for upper-limb kinematic analysis in paediatric movement disorders and relative normality data

    L. Garavaglia, E. Pagliano, A. Lo Mauro, G. Baranello, A. Aliverti, S. Pittaccio (Lecco, Italy)

    Objective: The study proposes a specialised protocol to collect and analyse kinematic data from paediatric patients affected by Movement Disorders (MD). The aim is to…
  • 2017 International Congress

    Antibody-Induced Failure of Botulinum Toxin Therapy: Restart with Incobotulinumtoxina Offers a New Opportunity

    D. Dressler, F. Adib Saberi (Hamburg, Germany)

    Objective: To study whether incobotulinumtoxinA (INCO), a new, low-antigenicity botulinum toxin (BT) drug, increases BT antibody (BTAB) titers in patients with antibody-induced therapy failure (ABTF)…
  • 2017 International Congress

    Infusion Rate Dependent Acute Neuropathic Pain with Duopa™ in a Patient with Parkinson’s disease and Pre-Existing Neuropathy

    A. Shukla, R. Govindarajan, I. Asher (Columbia, MO, USA)

    Objective: To report a case of rate dependent acute neuropathic pain with Duopa™ in a Parkinson’s patient with preexisting neuropathy. Background: Subacute to chronic neuropathy…
  • « Previous Page
  • 1
  • …
  • 49
  • 50
  • 51
  • 52
  • 53
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley